GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BioRegenx BRGX · USD

Communication Services · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 3 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

BioRegenx annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In USD.

FY2025FY2024FY2023FY2022FY2021
Revenue$1.9m$2.3m$22,243$42,159$198,584
Operating income−$518,991−$22.8m−$110,000−$78,308−$165,000
Net income−$1.5m−$23.1m−$571,000−$78,308−$96,873
Free cash flow$29,915−$513,538−$62,710−$64,652−$151,064
Total assets$410,986$508,535$31,640$59,149$127,762
Shareholders' equity−$4.5m−$3.4m−$221,972−$201,542−$84,234

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.